{
    "2018-11-12": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer (PFE) Stock Moves -0.38%: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "stock moves",
                        "negative percentage"
                    ],
                    "sentiment_score": -0.38,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "These Biopharmas Could Cure Genetic Diseases — At $5 Million Apiece",
                "features": {
                    "keywords": [
                        "biopharmas",
                        "cure",
                        "genetic diseases",
                        "high cost"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Corbus Pharmaceuticals Holdings’ Performance in 2018",
                "features": {
                    "keywords": [
                        "Corbus Pharmaceuticals",
                        "performance",
                        "yearly review"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Cardinal Health a Top Socially Responsible Dividend Stock With 3.4% Yield (CAH)",
                "features": {
                    "keywords": [
                        "Cardinal Health",
                        "dividend stock",
                        "socially responsible",
                        "yield"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-12",
                "original_text": "Health Care Sector Update for 11/12/2018: EIDX, PTIE, LCI, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "health care sector",
                        "update",
                        "stocks"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "How Nektar Performed in the Third Quarter",
                "features": {
                    "keywords": [
                        "Nektar",
                        "third quarter",
                        "performance"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}